Chill Most small caps are down after the rally early this year. But it's still a shame b4 and after aducanumab we found our spot back at 13 cents. One more news on new varient we should be at 8 cents, then we will enter Nasdaq exactly on the day Nasdaq bubble bursts. Just the way Elliot likes to plans things ...